Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dabigatran Bioavailability with Clarithromycin
NCT02171585Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2008
- Primary completion
- Aug 2008
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of dabigatran in thromboembolism (2 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the concentration-time curve of the analyte in plasma over the time interval from 0 extrapolated to infinity (Total Dabigatran) and Maximum measured concentration of the analyte in plasma (Total Dabigatran). Started Jun 2008; status: completed.
02
Drugs
dabigatran
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT02171585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02171585.